CDT Equity Inc. (CDT) is a Healthcare stock trading at $2.95 (as of 2026-08-21), with a market capitalization of $2.32M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
CDT Equity, Inc. facilitates the development and commercialization of clinical assets. The company was founded in October 2021 and is headquartered in Naples, Florida.
CDT Equity helps facilitate the development and commercialization of clinical assets, aiming to generate value from those commercialization efforts.
The profit model depends on whether the company can successfully move clinical assets through development and into commercialization, since its core business is built around that process.
Business quality (Mixed): Clear business focus on clinical-asset development and commercialization, but there is no disclosed segment breakdown or operating KPI detail here, and the latest period shows a deeply negative operating margin.
| Price | $2.95 |
| Market Cap | $2.32M |
| Price / Book | 0.02 |
| FCF Yield | -300.9% |
| Revenue (TTM) | $15000.00 |
| Net Margin | -3566.7% |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Top Institutional Holder | COMERICA INC ($286000.00) |
| Institutional Holders Tracked | 10 |
| Sector | Healthcare |
| Industry | Pharmaceutical Products |
| CEO | Andrew Regan |
| Employees | 6 |
| Country | US |
| IPO Date | 2022-03-28 |
Data as of 2026-08-21.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.